---
category: listing
circular_id: eb60027deaa98fa3
date: '2026-01-21'
description: 14,70,000 equity shares of Shelter Pharma Limited issued on preferential
  basis pursuant to warrant conversion listed with effect from January 22, 2026.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={EFFF135C-0BA5-4D4A-ACD1-11966884F214}&noticeno=20260121-18&dt=01/21/2026&icount=18&totcount=27&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of preferential issue shares post-warrant conversion
  with lock-in periods, limited market impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260121-18&attachedId=
processing:
  attempts: 1
  content_hash: 3fa09f114a4e2259
  processed_at: '2026-01-21T13:01:22.236292'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-01-21T11:21:16+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={EFFF135C-0BA5-4D4A-ACD1-11966884F214}&noticeno=20260121-18&dt=01/21/2026&icount=18&totcount=27&flag=0
severity: low
source: bse
stocks:
- SHELTER
tags:
- listing
- new-securities
- preferential-allotment
- warrant-conversion
- equity-shares
- lock-in
title: Listing of New Securities of Shelter Pharma Limited
---

## Summary

BSE has listed 14,70,000 equity shares of Shelter Pharma Limited (Scrip Code: 543963) issued on a preferential basis to promoters and non-promoters pursuant to conversion of warrants. The new shares will commence trading from January 22, 2026, and rank pari-passu with existing equity shares.

## Key Points

- 14,70,000 equity shares of Rs. 10/- each issued at premium of Rs. 32.25/-
- Issue price: Rs. 42.25/- per share
- Distribution numbers: 14862793 to 16332792
- ISIN: INE013V01011
- Shares issued pursuant to conversion of warrants
- Trading commences: January 22, 2026
- Allotment dates: November 15, 2025 (735,000 shares) and November 17, 2025 (735,000 shares)

## Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for preferentially allotted securities.

## Compliance Requirements

- Trading members must note the listing of new securities
- Lock-in restrictions must be enforced as per schedule below
- New shares to be treated as ranking pari-passu with existing equity shares

## Important Dates

- **Allotment Date 1:** November 15, 2025 (735,000 shares)
- **Allotment Date 2:** November 17, 2025 (735,000 shares)
- **Trading Commencement:** January 22, 2026
- **Lock-in Expiry (Partial):** August 14-15, 2026 (for 10,03,800 shares)
- **Lock-in Expiry (Final):** August 15, 2027 (for 4,66,200 shares)

## Lock-in Schedule

| No. of Shares | Distribution Numbers | Lock-in Until |
|---------------|---------------------|---------------|
| 3,36,000 | 14862793 to 15198792 | August 14, 2026 |
| 3,99,000 | 15198793 to 15597792 | August 15, 2026 |
| 2,68,800 | 15597793 to 15866592 | August 15, 2026 |
| 4,66,200 | 15866593 to 16332792 | August 15, 2027 |

## Impact Assessment

**Market Impact:** Low - The preferential issue represents a relatively small addition to Shelter Pharma's equity base. With majority of shares (10,03,800) subject to lock-in until August 2026 and remaining 4,66,200 shares locked until August 2027, immediate trading volume impact will be minimal.

**Operational Impact:** Minimal - Standard listing procedure requiring no special trading arrangements. Trading members need only note the additional shares and applicable lock-in restrictions for compliance purposes.